GMIN, my question for you and for others is what if the issue is an SEC review and that is why they can't report on anything? If there is a link between the FDA and the SEC where they share information, then it does make sense where a company can't discuss anything until a complete review is done.

If this is what is happening with Generex / NGIO, it makes sense and while I do not like it, nothing can be done until it is done. If it is something else, then that is a whole different issue.

Am I upset? From all my other posts, you should be able to tell I am not happy with what is going on. Can I do anything about it? No. So, I am waiting to see what happens now.

We are in the teens in the PPS. I keep hoping, actually praying that things turn around for me, for you, for all of us. I still believe in the science. There are a lot of people who apparently have believed in the science to the tune of 2.5 billion dollars apparently, so I am in good company. They also have Excellegan, they also have those clinics.

Because of all of this, I am still not giving up on Generex / NGIO 'yet'. I am frustrated, sometimes angry, I vent a lot, but I also know that this company is worth more than 20 million dollars or so, way more. And sooner or later, something has got to break open for them, for all of us.

Sooner or later...